Description
Nintedanib, marketed under the brand name OFEV, It is an prescription medication that has been approved nintedanib (Ofev) for oral use on October 15, 2014. The European Medicines Agency approved it in January 2015, and it is also approved in Canada, Japan, Switzerland, and other countries.
What is Ofev (nintedanib) ?
Ofev is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC),
- that has certain types of abnormal epidermal growth factor receptor (EGFR) genes, and
- who have not had previous treatment for cancer that has spread to other parts of the body
It is not known if Ofev is safe and effective in children.
Ofev is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
Quote From FDA
How to order approved “Ofev (nintedanib) for ” Medicine?
OFEV (Nintedanib) capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing OFEV and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
